NCT04685213View on ClinicalTrials.gov

Electrical Stimulation for Critically Ill Covid-19 Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

December 22, 2020

Primary Completion Date

March 18, 2021

Study Completion Date

March 18, 2021

Conditions
Covid19Muscle AtrophyMuscle Weakness
Interventions
DEVICE

Electrical Stimulation

Subjects will receive an active electrical stimulation device to wear for 1 hour daily up to two weeks or until hospital discharge, whichever came first (phase I).

DEVICE

Electrical Stimulation - Sham

Subjects will receive a sham electrical stimulation device to wear for 1 hour daily up to two weeks or until hospital discharge, whichever came first (phase I).

Trial Locations (1)

77030

Baylor College of Medicine, Houston

All Listed Sponsors
collaborator

Avazzia, Inc

INDUSTRY

lead

Baylor College of Medicine

OTHER

NCT04685213 - Electrical Stimulation for Critically Ill Covid-19 Patients | Biotech Hunter | Biotech Hunter